15 July 2014
NPTs Biotechnology, a spin-off of Russia’s Institute of Design and Technology Informatics, is working on what is believed to be a next-generation robotic complex for surgeries, the Skolkovo Foundation website reported .
The project team is said to have succeeded in developing a brand new kinematic manipulator based on parallel structure mechanisms, which helped make the new system more compact and accurate and less expensive, compared to existing analogs such as the da Vinci surgical system.
This coming fall the young company wants to conduct a first series of animal tests. Dmitry Pushkar, a leading Russian urologist and surgeon, is leading the medical aspects of the effort.
Last month, the Russian Trade Representative in Finland helped NPTs Biotechnology present the project to a wide circle of potential stakeholders from among Finnish investors and partners.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
The first Russian device for testing TB is registered
14 January 2025
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025